PetVivo Holdings Beheer

Beheer criteriumcontroles 2/4

De CEO PetVivo Holdings is John Lai, benoemd in Jul2019, heeft een ambtstermijn van 5.33 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 497.41K, bestaande uit 70.4% salaris en 29.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 6.69% van de aandelen van het bedrijf, ter waarde $ 751.74K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.3 jaar en 2 jaar.

Belangrijke informatie

John Lai

Algemeen directeur

US$497.4k

Totale compensatie

Percentage CEO-salaris	70.4%
Dienstverband CEO	5.3yrs
Eigendom CEO	6.7%
Management gemiddelde ambtstermijn	4.3yrs
Gemiddelde ambtstermijn bestuur	2yrs

Recente managementupdates

Recent updates

Companies Like PetVivo Holdings (NASDAQ:PETV) Could Be Quite Risky

Nov 11

Will PetVivo Holdings (NASDAQ:PETV) Spend Its Cash Wisely?

Jul 26

PetVivo Holdings GAAP EPS of -$0.57 beats by $0.37, revenue of $0.1M misses by $1.6M

Jun 29

We Think PetVivo Holdings (NASDAQ:PETV) Can Afford To Drive Business Growth

Mar 23

Analyse CEO-vergoeding

Hoe is John Lai's beloning veranderd ten opzichte van PetVivo Holdings's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-US$10m
Mar 31 2024	US$497k	US$350k	-US$11m
Dec 31 2023	n/a	n/a	-US$11m
Sep 30 2023	n/a	n/a	-US$11m
Jun 30 2023	n/a	n/a	-US$10m
Mar 31 2023	US$488k	US$306k	-US$9m
Dec 31 2022	n/a	n/a	-US$8m
Sep 30 2022	n/a	n/a	-US$7m
Jun 30 2022	n/a	n/a	-US$6m
Mar 31 2022	US$710k	US$202k	-US$5m
Dec 31 2021	n/a	n/a	-US$4m
Sep 30 2021	n/a	n/a	-US$3m
Jun 30 2021	n/a	n/a	-US$3m
Mar 31 2021	US$240k	US$92k	-US$4m
Dec 31 2020	n/a	n/a	-US$4m
Sep 30 2020	n/a	n/a	-US$3m
Jun 30 2020	n/a	n/a	-US$2m
Mar 31 2020	US$511k	US$35k	-US$2m
Dec 31 2019	n/a	n/a	-US$3m
Sep 30 2019	n/a	n/a	-US$3m
Jun 30 2019	n/a	n/a	-US$3m
Mar 31 2019	US$60k	US$60k	-US$5m
Dec 31 2018	n/a	n/a	-US$4m
Sep 30 2018	n/a	n/a	-US$4m
Jun 30 2018	n/a	n/a	-US$4m
Mar 31 2018	US$126k	US$51k	-US$2m

Compensatie versus markt: De totale vergoeding ($USD 497.41K ) John } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 651.15K ).

Compensatie versus inkomsten: De vergoeding van John is gestegen terwijl het bedrijf verliesgevend is.

CEO

John Lai (62 yo)

5.3yrs

Tenure

US$497,412

Compensatie

Mr. John Lai has been the President of PetVivo Holdings, Inc. since July 17, 2017 and has been its Chief Executive Officer since July 16, 2019 and has been its Director since March 2014. Mr. Lai served as...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
John Lai	CEO, President & Director	5.3yrs	US$497.41k	6.69% $ 751.7k
Garry Lowenthal	Chief Financial Officer	less than a year	US$32.78k	0.90% $ 100.7k
Randall Meyer	Chief Operating Officer	3.2yrs	US$306.10k	3.15% $ 353.6k
Randy Wenthold	Chief Science Officer	6.9yrs	geen gegevens	geen gegevens
John Dolan	General Counsel	5.3yrs	US$113.54k	2.95% $ 330.8k
Gary DeMel	Executive Vice President of Business Development	8.3yrs	geen gegevens	geen gegevens
April Boyce	Vice President of Marketing	less than a year	geen gegevens	geen gegevens
Bryan Monninger	Vice President of Sales	less than a year	geen gegevens	geen gegevens

4.3yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van PETV wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
John Lai	CEO, President & Director	10.7yrs	US$497.41k	6.69% $ 751.7k
Robert Rudelius	Independent Director	6.3yrs	US$27.63k	1.03% $ 116.0k
Joseph Jasper	Independent Director	6.3yrs	US$27.63k	0.36% $ 40.1k
Robert Costantino	Independent Director	2.3yrs	US$27.63k	0.22% $ 25.0k
Mike Eldred	Independent Director	less than a year	geen gegevens	0.17% $ 19.6k
Tracy Turner	Member of Advisory Board	no data	geen gegevens	geen gegevens
Sherman Canapp	Member of Advisory Board	less than a year	geen gegevens	geen gegevens
Spencer Breithaupt	Independent Director	1.6yrs	US$71.35k	0% $ 0
Diane Levitan	Independent Director	less than a year	US$31.26k	0.17% $ 19.6k

2.0yrs

Gemiddelde duur

62.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van PETV wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2 jaar), wat duidt op een nieuw bestuur.

PetVivo Holdings Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

PetVivo Holdings, Inc. Appoints Mike Eldred as Member of Board

Petvivo Holdings, Inc. Appoints Garry Lowenthal as Its New Chief Financial Officer

PetVivo Holdings, Inc. Approves Election of Diane Levitan as Member of the Board

PetVivo Holdings, Inc., Annual General Meeting, Nov 17, 2023

Independent Chairman of the Board recently bought US$51k worth of stock

PetVivo Holdings, Inc., Annual General Meeting, Oct 14, 2022

Recent updates

PetVivo Holdings, Inc. Appoints Mike Eldred as Member of Board

Nasdaq Files Form 25 to Delist Securities of PetVivo Holdings

The Nasdaq Stock Market to Delist Common Stock of PetVivo Holdings

PetVivo Holdings, Inc. Reiterates Revenue Guidance for the Full Year 2025

PetVivo Holdings, Inc. to Report Q1, 2025 Results on Aug 14, 2024

PetVivo Holdings Receives a Non-Compliance Letter from the Nasdaq Stock Market

PetVivo Holdings, Inc. announced that it has received $1.21 million in funding

PetVivo Holdings, Inc. to Report Q4, 2024 Results on Jun 28, 2024

PetVivo Holdings, Inc.(OTCPK:PETV) dropped from S&P TMI Index

PetVivo Holdings Receives Determination Letter from the Nasdaq Hearings Panel Due to Failure to Regain Compliance with the Nasdaq Listing Rule 5550(b) by April 1, 2024

PetVivo Holdings, Inc.(OTCPK:PETV) dropped from NASDAQ Composite Index

Petvivo Holdings, Inc. Appoints Garry Lowenthal as Its New Chief Financial Officer

PetVivo Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $0.959033 million.

Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.23 loss in 3Q 2023)

PetVivo Holdings, Inc. to Report Q3, 2024 Results on Feb 12, 2024

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-Articular Injections of Spryng with OsteoCushion Technology

Petvivo Receives Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

PetVivo Holdings Receives Written Notice from Nasdaq Regarding Non-Compliance with the Minimum Stockholders’ Equity Requirement Under Nasdaq Listing Rule 5550(b)(1)

New major risk - Market cap size

PetVivo Holdings, Inc. Approves Election of Diane Levitan as Member of the Board

New major risk - Financial position

Second quarter 2024 earnings released: US$0.28 loss per share (vs US$0.21 loss in 2Q 2023)

PetVivo Holdings, Inc. to Report Q2, 2024 Results on Nov 14, 2023

PetVivo Holdings, Inc., Annual General Meeting, Nov 17, 2023

Independent Chairman of the Board recently bought US$51k worth of stock

PetVivo Receives Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

First quarter 2024 earnings released: US$0.25 loss per share (vs US$0.20 loss in 1Q 2023)

PetVivo Holdings, Inc. to Report Q1, 2024 Results on Aug 10, 2023

New minor risk - Share price stability

Full year 2023 earnings: EPS and revenues miss analyst expectations

PetVivo Holdings, Inc. to Report Fiscal Year 2023 Results on Jun 29, 2023

PetVivo Holdings, Inc. Begins Process to Pursue Approval of Biomatrix Particulate Technology for Initial Human Indication

Third quarter 2023 earnings released: US$0.23 loss per share (vs US$0.17 loss in 3Q 2022)

PetVivo Holdings, Inc. to Report Q3, 2023 Results on Feb 09, 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Companies Like PetVivo Holdings (NASDAQ:PETV) Could Be Quite Risky

PetVivo Holdings, Inc. to Report Q2, 2023 Results on Nov 10, 2022

Petvivo Holding, Inc. Announces Spryng™ Now Available to Veternarians Through Mwi Animal Health

PetVivo Holdings, Inc., Annual General Meeting, Oct 14, 2022

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

PetVivo Holdings, Inc. to Report Q1, 2023 Results on Aug 11, 2022

PetVivo Holdings, Inc. Announces Board Appointments

Will PetVivo Holdings (NASDAQ:PETV) Spend Its Cash Wisely?

PetVivo Holdings GAAP EPS of -$0.57 beats by $0.37, revenue of $0.1M misses by $1.6M

Full year 2022 earnings: EPS and revenues miss analyst expectations

PetVivo Holdings, Inc. to Report Fiscal Year 2022 Results on Jun 29, 2022

We Think PetVivo Holdings (NASDAQ:PETV) Can Afford To Drive Business Growth

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

PetVivo Holdings, Inc. to Report Q3, 2022 Results on Feb 10, 2022

Second quarter 2022 earnings released: US$0.13 loss per share (vs US$0.23 loss in 2Q 2021)

First quarter 2022 earnings released: US$0.071 loss per share (vs US$0.14 loss in 1Q 2021)

PetVivo Holdings Common Stock Deleted from Other OTC

High number of new directors

Petvivo Holdings, Inc. Enters into University Services Agreement with Colorado State University

PetVivo Holdings, Inc. announced that it has received $0.6 million in funding from RedDiamond Partners LLC

Petvivo Holdings, Inc. Appoints Dr. David B. Masters as Director of Science and Technology

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd